SASH1 inhibits cervical cancer cell proliferation and invasion by suppressing the FAK pathway

Hui Chen1, Dongliang Wang1, Yuling Liu1

  • 1Department of Gynecology and Obstetrics, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450014, P.R. China.

Insights

SAM and SH3 domain containing 1 (SASH1) acts as a tumor suppressor in cervical cancer. Its downregulation promotes cancer cell proliferation and invasion by activating the FAK pathway, suggesting SASH1 as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • SAM and SH3 domain containing 1 (SASH1) is implicated as a tumor suppressor in various cancers.
  • The specific function and mechanism of SASH1 in cervical cancer pathogenesis are not well understood.

Purpose of the Study:

  • To investigate the role of SASH1 in cervical cancer.
  • To elucidate the underlying molecular mechanisms by which SASH1 influences cervical cancer progression.

Main Methods:

  • Quantitative analysis of SASH1, MMP-2, and MMP-9 mRNA expression via RT-qPCR.
  • Western blot analysis for SASH1, MMP-2, MMP-9, and FAK protein levels.
  • Assessment of cell proliferation using MTT assay and cell invasion via Transwell assay.

Main Results:

  • SASH1 expression was significantly downregulated in cervical cancer tissues and cell lines.
  • Overexpression of SASH1 suppressed cervical cancer cell proliferation and invasion.
  • SASH1 overexpression reduced MMP-2 and MMP-9 expression and inhibited the FAK signaling pathway.

Conclusions:

  • SASH1 functions as a tumor suppressor in cervical cancer.
  • SASH1 inhibits cervical cancer cell proliferation and invasion by downregulating the FAK signaling pathway.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.5K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.8K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.2K